ClinicalTrials.Veeva

Menu

Sublingual Administration of PPI

T

The Catholic University of Korea

Status

Unknown

Conditions

Gastric or Duodenal Ulcer

Study type

Observational

Funder types

Other

Identifiers

NCT01926600
24 hour pH

Details and patient eligibility

About

Compare 24-hour intragastric pH and therapeutic effectiveness of proton pump inhibitor (PPI) among different administration methods: per oral (PO), intravenous (IV), and sublingual (SL).

Full description

Intragastric pH and therapeutic effectiveness of PPI was compared among patients given PPI with different administration methods. 24 hour intragastric pH catheter was inserted in stomach of patients with peptic ulcer an hour prior to PPI administration in order to observe the initial change in pH. Three groups of patients were given PPI through per oral, intravenous, and sublingual administration methods. The hypothesis of this study is that sublingual administration will be faster than oral or IV administration in PPI dosing with respect to intragastric pH change and re-bleeding rate.

Enrollment

60 estimated patients

Sex

All

Ages

20 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with peptic ulcer disease
  • Age: 20-75 years old
  • Patients who submitted informed consent

Exclusion criteria

  • Peptic ulcer disease with spurting and oozing
  • Shock, hypotension, pregnancy
  • Gastrointestinal malignancy

Trial design

60 participants in 3 patient groups

PO
Description:
administrated by per oral
IV
Description:
Administrated by intravenous
SL
Description:
administrated by sublingual

Trial contacts and locations

1

Loading...

Central trial contact

Jin Il Kim, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems